Assignee
AVENTIS PHARMA INC
US·189 granted patents·73 pending applications·3,043 citations·filing 1993–2013
Top patents by PatentIndex Score
262 records- 0199US6528526B1Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2000·Granted Mar 4, 2003·305 cites·37 claims
- 0299US6524347B1Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2000·Granted Feb 25, 2003·307 cites·11 claims
- 0398US6482834B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2001·Granted Nov 19, 2002·254 cites·50 claims
- 0496US6897208B2BenzimidazolesAVENTIS PHARMA INC·Filed 2002·Granted May 24, 2005·168 cites·38 claims
- 0595US6897207B2AzaindolesAVENTIS PHARMA INC·Filed 2002·Granted May 24, 2005·120 cites·50 claims
- 0693US6645969B1Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinaseAVENTIS PHARMA INC·Filed 1995·Granted Nov 11, 2003·74 cites·12 claims
- 0792US7943616B2Azaindoles for inhibiting aurora2 and other kinasesAVENTIS PHARMA INC·Filed 2004·Granted May 17, 2011·61 cites·1 claims
- 0892US7772252B2Heterocyclic substituted carbonyl derivatives and their use as dopamine D3 receptor ligandsAVENTIS PHARMA INC·Filed 2009·Granted Aug 10, 2010·22 cites·20 claims
- 0991US7977310B2Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetesAVENTIS PHARMA INC·Filed 2008·Granted Jul 12, 2011·19 cites·10 claims
- 1091US7405196B2Method for reducing cardiovascular morbidity and mortality in prediabetic patients and patients with type 2 diabetesAVENTIS PHARMA INC·Filed 2004·Granted Jul 29, 2008·43 cites·48 claims
- 1191USRE39198EHeteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgesicsAVENTIS PHARMA INC·Filed 2000·Granted Jul 18, 2006·19 cites·147 claims
- 1291US6846815B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2003·Granted Jan 25, 2005·28 cites·18 claims
- 1390US6140345A1-(aryloxyalkyl)-4-(heteroaryl)piperidines and related compounds useful as antipsychotics and analgesicsAVENTIS PHARMA INC·Filed 1995·Granted Oct 31, 2000·32 cites·67 claims
- 1489US6413974B16,9,-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purinesAVENTIS PHARMA INC·Filed 1999·Granted Jul 2, 2002·94 cites·27 claims
- 1588US7253165B2Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonistsAVENTIS PHARMA INC·Filed 2004·Granted Aug 7, 2007·24 cites·211 claims
- 1687US7517889B22,6-substituted-4-monosubstitutedamino-pyrimidine as prostaglandin D2 receptor antagonistsAVENTIS PHARMA INC·Filed 2007·Granted Apr 14, 2009·11 cites·13 claims
- 1787US7326792B2Heterocyclic compounds as P2X7 ion channel blockersAVENTIS PHARMA INC·Filed 2004·Granted Feb 5, 2008·29 cites·26 claims
- 1887US7179821B2Method of treating of demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2005·Granted Feb 20, 2007·7 cites·2 claims
- 1987US6881555B2AKT nucleic acids, polypeptides, and uses thereofAVENTIS PHARMA INC·Filed 2000·Granted Apr 19, 2005·15 cites·50 claims
- 2087US6693072B2Elastase inhibitorsAVENTIS PHARMA INC·Filed 2000·Granted Feb 17, 2004·21 cites·11 claims
- 2186US8008491B2Substituted AZA-indoles as inhibitors of poly(ADP-ribose) polymerase (PARP)AVENTIS PHARMA INC·Filed 2008·Granted Aug 30, 2011·15 cites·2 claims
- 2286US7138524B2Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereofAVENTIS PHARMA INC·Filed 2002·Granted Nov 21, 2006·16 cites·1 claims
- 2386US7109161B1Preserved pharmaceutical formulationsAVENTIS PHARMA INC·Filed 2000·Granted Sep 19, 2006·36 cites·45 claims
- 2486US6479487B16, 9-disubstituted 2-[trans-(4-aminocyclohexyl)amino] purinesAVENTIS PHARMA INC·Filed 1999·Granted Nov 12, 2002·78 cites·193 claims
- 2585US7741493B2Heterocyclic compounds as P2X7 ion channel blockersAVENTIS PHARMA INC·Filed 2007·Granted Jun 22, 2010·8 cites·10 claims
- 2685US7230015B2Method of treating of demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2005·Granted Jun 12, 2007·5 cites·2 claims
- 2784US7259154B2PyrrolopyrimidinesAVENTIS PHARMA INC·Filed 2003·Granted Aug 21, 2007·26 cites·16 claims
- 2884US6977263B2Chemical compoundsAVENTIS PHARMA INC·Filed 2001·Granted Dec 20, 2005·27 cites·59 claims
- 2984US6967210B2Method of treating of demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2002·Granted Nov 22, 2005·14 cites·24 claims
- 3084US6696434B2Quinoline and quinoxaline compounds which inhibit platelet-derived growth factor and/or p56lck tyrosine kinasesAVENTIS PHARMA INC·Filed 2002·Granted Feb 24, 2004·14 cites·62 claims
- 3184US6512161B1Transgenic rabbit that expresses a functional human lipoprotein (a)AVENTIS PHARMA INC·Filed 1999·Granted Jan 28, 2003·76 cites·22 claims
- 3284US6113942APharmaceutical composition for piperidinoalkanol compoundsAVENTIS PHARMA INC·Filed 1998·Granted Sep 5, 2000·36 cites·5 claims
- 3383US7754678B2Membrane penetrating peptides and uses thereofAVENTIS PHARMA INC·Filed 2005·Granted Jul 13, 2010·8 cites·12 claims
- 3483US7534803B2Method of treating demyelinating diseases or conditionsAVENTIS PHARMA INC·Filed 2005·Granted May 19, 2009·4 cites·2 claims
- 3583US6613779B2Use of R(+) -α-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piper idinemethanol for the treatment of sleep disordersAVENTIS PHARMA INC·Filed 2001·Granted Sep 2, 2003·18 cites·25 claims
- 3682US6576647B2Pseudopolymorph of (—)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4R-(3S-hydroxy -1-methyl)piperidinyl]-4H-1-benzopyran-4-oneAVENTIS PHARMA INC·Filed 2001·Granted Jun 10, 2003·25 cites·22 claims
- 3782US6472505B1Peptide parathyroid hormone analogsAVENTIS PHARMA INC·Filed 1999·Granted Oct 29, 2002·67 cites·8 claims
- 3882US6376472B1Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic propertiesAVENTIS PHARMA INC·Filed 1998·Granted Apr 23, 2002·24 cites·15 claims
- 3982US6194406B1Substituted 4-(1H-benzimidazol-2-yl)[1,4]diazepanes useful for the treatment of allergic diseaseAVENTIS PHARMA INC·Filed 1997·Granted Feb 27, 2001·33 cites·161 claims
- 4081US7625889B2Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonistsAVENTIS PHARMA INC·Filed 2007·Granted Dec 1, 2009·7 cites·12 claims
- 4181US6399633B1Use of 4-H-1-benzopryan-4-one derivatives as inhibitors of smooth muscle cell proliferationAVENTIS PHARMA INC·Filed 1999·Granted Jun 4, 2002·61 cites·15 claims
- 4280US7169925B2Indole derivatives as interleukin-4 gene expression inhibitorsAVENTIS PHARMA INC·Filed 2003·Granted Jan 30, 2007·14 cites·11 claims
- 4380US6794410B2Use of (Z)-2-cyano-3-hydroxy-but-2-enoic acid-(4′-trifluoromethylphenyl)-amide for treating multiple sclerosisAVENTIS PHARMA INC·Filed 2002·Granted Sep 21, 2004·21 cites·1 claims
- 4480US6555328B1Screening methods for altering circadian rhythms and for human casein kinase I δ and/or ε phosphorylation of human clock proteins, period 1, -2 and -3AVENTIS PHARMA INC·Filed 2000·Granted Apr 29, 2003·24 cites·57 claims
- 4580US6211199B1Substituted 4-(1H-benzimidazol-2-yl-amino)piperidines useful for the treatment of allergic diseasesAVENTIS PHARMA INC·Filed 1997·Granted Apr 3, 2001·29 cites·119 claims
- 4679US7056720B2LLG polypeptides of the triacylglycerol lipase family, and compositions and methods for their use in enzymatic hydrolysis, and protein and gene therapiesAVENTIS PHARMA INC·Filed 2002·Granted Jun 6, 2006·8 cites·9 claims
- 4778US7135571B2Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereofAVENTIS PHARMA INC·Filed 2002·Granted Nov 14, 2006·9 cites·1 claims
- 4878US6638717B2Microarray-based subtractive hybridzationAVENTIS PHARMA INC·Filed 1999·Granted Oct 28, 2003·82 cites·5 claims
- 4978US6451815B1Method of enhancing bioavailability of fexofenadine and its derivativesAVENTIS PHARMA INC·Filed 1999·Granted Sep 17, 2002·68 cites·30 claims
- 5077US7642249B2Dihydrogen phosphate salt of a prostaglandin D2 receptor antagonistAVENTIS PHARMA INC·Filed 2008·Granted Jan 5, 2010·6 cites·3 claims
Showing the top 50 of 262 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →